These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31727779)

  • 1. Polypharmacy and deprescribing: just ask the patient.
    Cave JA
    Drug Ther Bull; 2020 Jan; 58(1):2. PubMed ID: 31727779
    [No Abstract]   [Full Text] [Related]  

  • 2. Deprescribing: A simple method for reducing polypharmacy.
    McGrath K; Hajjar ER; Kumar C; Hwang C; Salzman B
    J Fam Pract; 2017 Jul; 66(7):436-445. PubMed ID: 28700758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review.
    Sawan M; Reeve E; Turner J; Todd A; Steinman MA; Petrovic M; Gnjidic D
    Expert Rev Clin Pharmacol; 2020 Mar; 13(3):233-245. PubMed ID: 32056451
    [No Abstract]   [Full Text] [Related]  

  • 4. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fit fOR The Aged (FORTA) project and its clinical implications.
    Pazan F; Wehling M
    Expert Opin Drug Metab Toxicol; 2020 Apr; 16(4):275-277. PubMed ID: 32163717
    [No Abstract]   [Full Text] [Related]  

  • 6. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
    Reeve E; Moriarty F; Nahas R; Turner JP; Kouladjian O'Donnell L; Hilmer SN
    Expert Opin Drug Saf; 2018 Jan; 17(1):39-49. PubMed ID: 29072544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.
    Carrier H; Zaytseva A; Bocquier A; Villani P; Verdoux H; Fortin M; Verger P
    Br J Gen Pract; 2019 Apr; 69(681):e270-e278. PubMed ID: 30803978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing medication burden and polypharmacy: finding the perfect measure.
    Gnjidic D; Tinetti M; Allore HG
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):345-347. PubMed ID: 28271722
    [No Abstract]   [Full Text] [Related]  

  • 9. Deprescribing Is an Essential Part of Good Prescribing.
    Farrell B; Mangin D
    Am Fam Physician; 2019 Jan; 99(1):7-9. PubMed ID: 30600973
    [No Abstract]   [Full Text] [Related]  

  • 10. Deprescribing medications in older people: a narrative review.
    Salahudeen MS
    Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swimming Against the Tide: Primary Care Physicians' Views on Deprescribing in Everyday Practice.
    Wallis KA; Andrews A; Henderson M
    Ann Fam Med; 2017 Jul; 15(4):341-346. PubMed ID: 28694270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is my older cancer patient on too many medications?
    Turner JP; Shakib S; Bell JS
    J Geriatr Oncol; 2017 Mar; 8(2):77-81. PubMed ID: 27840102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MEDICATIONS DEPRESCRIBING IN ELDERLY NURSING HOME RESIDENTS].
    Aizen E; Hindawil E; Hijazi M; Merih A; Shahla H; Elyounes AA
    Harefuah; 2016 Mar; 155(3):145-9, 197. PubMed ID: 27305746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing inappropriate polypharmacy: the process of deprescribing.
    Scott IA; Hilmer SN; Reeve E; Potter K; Le Couteur D; Rigby D; Gnjidic D; Del Mar CB; Roughead EE; Page A; Jansen J; Martin JH
    JAMA Intern Med; 2015 May; 175(5):827-34. PubMed ID: 25798731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deprescribing: a new goal focused on the patient.
    Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
    Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoughtful Prescribing and Deprescribing.
    Pravodelov V
    Med Clin North Am; 2020 Sep; 104(5):751-765. PubMed ID: 32773043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geriatric Polypharmacy: Two Physicians' Personal Perspectives.
    Chen Z; Buonanno A
    Clin Geriatr Med; 2017 May; 33(2):283-288. PubMed ID: 28364996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians need to take the lead in deprescribing.
    Scott IA; Le Couteur DG
    Intern Med J; 2015 Mar; 45(3):352-6. PubMed ID: 25735580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
    Anderson K; Freeman C; Foster M; Scott I
    J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.
    Chou J; Tong M; Brandt NJ
    J Gerontol Nurs; 2019 Jan; 45(1):9-15. PubMed ID: 30653232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.